Here is Why CRISPR Therapeutics (CRSP) Appears so Good

On February 17, Morgan Stanley accrued its terms people connected CRISPR Therapeutics AG (NASDAQ:CRSP) from $32 to $33, portion maintaining an Underweight standing connected the stock.

The steadfast updated its estimates for CRISPR Therapeutics AG (NASDAQ:CRSP) and evaluated further pipeline advancements aft its spouse Vertex Pharmaceuticals (VRTX) disclosed fourth-quarter income information of Casgevy.

On February 13, Needham accrued the firm’s terms people connected CRISPR Therapeutics AG (NASDAQ:CRSP) from $80 to $82. The steadfast maintained its Buy standing connected the shares that connection much than 45% upside imaginable aft the revision.

Following the company’s Q4 results, the steadfast noted that Casgevy generated $116 cardinal successful income successful 2025, surpassing Vertex’s antecedently stated people of astir $100 million. The stronger-than-expected income show highlights aboriginal commercialized traction for the therapy, supporting a affirmative outlook for the company.

CRISPR Therapeutics AG (NASDAQ:CRSP) is simply a cistron editing institution processing perchance curative medicines for superior diseases. Their groundbreaking therapy CASGEVY targets sickle compartment illness and humor disorders, portion their broader pipeline tackles cancer, autoimmune conditions, and diabetes. This has positioned them arsenic a person successful the aboriginal of familial medicine.

While we admit the imaginable of CRSP arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and 12 Oversold Financial Stocks to Invest successful According to Hedge Funds.

Disclosure: None. Follow Insider Monkey connected Google News.